• Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole.

  • Interim report May – October 2019

  • Oasmia launches the ovarian cancer treatment drug Apealea® in Sweden, Denmark and Finland

  • Watch clip, including interviews with our Chief Medical Officer and Chief Business Officer.

The Share